Neuwelt) 2752 (Springer US, 1989)
However, no human safety data from controlled clinical trials currently exists
FDA currently lists BPC-157 among compounding substances for which it has identified potential immunogenicity, peptide-impurity, and API-characterization concerns, while noting that it has limited safety information for proposed routes of administration
Questions people ask about DSIP and other sleep aids Is DSIP the same as melatonin
However, CF, PCD, and NCFB are rarer with incidences ranging from 1 in 20,000 for PCD, between 50 and 1,000 in 100,000 for NCFB, and around 160,000 individuals with CF worldwide (Nigro et al., 2024
While no official human dosing guidelines exist, anecdotal use and rodent-to-human conversions help shape general best practices